Researcher
Maria Debiec-Rychter
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From1 Jul 2009 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 30 Jun 2009
Projects
1 - 4 of 4
- Human soft tissue sarcomas xenograft mouse models as an opportunity to improve the therapeutic options for patients.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Identification of novel protein kinase targets for the improvement of gastrointestinal stromal tumor (GIST) therapy: a paradigm for the optimisation of kinase targeted therapies.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project
- Deregulated signaling pathways in cancer: from genetic insights towards targeted therapy.From1 Oct 2010 → 30 Nov 2016Funding: BOF - Concerted Research Project from 1994
- The biological and therapeutic importance of CCK-2/gastrin receptor in gastrointestinal stromal tumors (GISTs).From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
Publications
41 - 50 of 194
- Activity and safety of crizotinib in patients with advanced clear cell sarcoma with MET alterations. European Organization for Research and Treatment of Cancer phase 2 trial 90101 "CREATE"(2017)
Authors: Patrick Schöffski, Agnieszka Wozniak, Raf Sciot, Maria Debiec-Rychter, Tom van Cann
Pages: 3000 - 3008 - In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets(2017)
Authors: Raf Sciot, Maria Debiec-Rychter
Pages: 7426 - 7434 - New targets and therapies for gastrointestinal stromal tumors(2017)
Authors: Agnieszka Wozniak, Maria Debiec-Rychter, Patrick Schöffski
Pages: 1117 - 1129 - Prognostic Value of Molecular Alterations in Infantile Spindle Cell Rhabdomyosarcoma(2017)
Authors: Enrico Pozzo, Maria Debiec-Rychter, Raf Sciot, M Renard, Anne Uyttebroeck, H Segers
Pages: S264 - S265 - A novel EWS-CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcoma(2017)
Authors: Barbara Dewaele, Louis Libbrecht, Raf Sciot, Maria Debiec-Rychter
Pages: 695 - 699 - In vivo antitumoral efficacy of PhAc-ALGP-doxorubicin, an enzyme-activated doxorubicin prodrug, in patient-derived soft tissue sarcoma xenograft models(2017)
Authors: Jasmien Cornillie, Agnieszka Wozniak, Peter Pokreisz, Andrea Casazza, Yemarshet Kelemework Gebreyohannes, Maria Debiec-Rychter, Raf Sciot, Daphne Hompes, Patrick Schöffski
Pages: 1566 - 1575 - Phalangeal chondrosarcoma: A rare presentation with an unusual biological behavior(2017)
Authors: Ilse Degreef, Steven Pans, Maria Debiec-Rychter, Raf Sciot
Pages: 228 - 229 - Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas(2017)
Authors: Barbara Dewaele, Jan Cools, Maria Debiec-Rychter
- Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation(2017)
Authors: Maria Debiec-Rychter
Pages: 1134 - 1141 - PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis(2017)
Authors: Raf Sciot, Maria Debiec-Rychter
Pages: 1801 - 1810